ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-14M17606
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Drug Metabolism and Pharmacokinetics DMPK Service Market Research Report 2024
BUY CHAPTERS

Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Research Report 2024

Code: QYRE-Auto-14M17606
Report
June 2024
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
NuChem Sciences Inc
Sygnature Discovery
Paraza Pharma, Inc
Dalriada
Inotiv, Inc.
Eurofins Discovery
RTI International
Frontage Labs
LabCorp
Jubilant Biosys
Creative-Biolabs
Evotec AG
Charles River
Invitrocue
Q 2 Solutions
WuXi AppTec
Alliance Pharma Inc.
Nuvisan
Anthem Bio Sciences
Molecular Diagnostic Services, Inc
TCG Lifesciences Private Limited
oncodesign service
QPS Holdings

Drug Metabolism and Pharmacokinetics (DMPK) Service Market

Drug Metabolism and Pharmacokinetics (DMPK) Service help support drug developers in understanding the Absorption, Distribution, Metabolism, and Excretion (ADME) processes of specific compounds or drugs. DMPK projects cover a drug development program from the discovery, candidate selection, Investigational New Drug (IND) enabling, through New Drug Application (NDA) stages. ADME is a subset of DMPK, focusing on the absorption, distribution, metabolism, and excretion of drugs. In addition to ADME, DMPK adds pharmacokinetics including considerations of dosage regimens, optimal dosage frequencies, and factors affecting drug efficacy and safety. DMPK studies are crucial in evaluating the pharmacokinetic behavior of potential drug candidates, optimizing dosing regimens, and bridging their safety and efficacy before advancing to later stages of development. DMPK studies include a range of in vitro and in vivo assays to understand how the body interacts with a drug or compound. To be more specific, these studies include in vitro ADME (Absorption, Distribution, Metabolism, and Excretion), rodent pharmacokinetics, large animal pharmacokinetics, metabolites profiling and identification, mass balance and tissue distribution, etc.
The global Drug Metabolism and Pharmacokinetics (DMPK) Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Drug Metabolism and Pharmacokinetics (DMPK) Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Drug Metabolism and Pharmacokinetics (DMPK) Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Drug Metabolism and Pharmacokinetics (DMPK) Service in Pharmaceutical Research and Development is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Drug Metabolism and Pharmacokinetics (DMPK) Service include NuChem Sciences Inc, Sygnature Discovery, Paraza Pharma, Inc, Dalriada, Inotiv, Eurofins Discovery, RTI International, Frontage Labs, Labcorp, Jubilant Biosys, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drug Metabolism and Pharmacokinetics (DMPK) Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Metabolism and Pharmacokinetics (DMPK) Service.
The Drug Metabolism and Pharmacokinetics (DMPK) Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Metabolism and Pharmacokinetics (DMPK) Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Metabolism and Pharmacokinetics (DMPK) Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Drug Metabolism and Pharmacokinetics (DMPK) Service Market Report

Report Metric Details
Report Name Drug Metabolism and Pharmacokinetics (DMPK) Service Market
Segment by Type
  • In Vivo Drug Metabolism and Pharmacokinetics Services
  • In Vitro Drug Metabolism and Pharmacokinetics Services
Segment by Application
  • Pharmaceutical Research and Development
  • Biotechnology
  • Efficacy Testing
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company NuChem Sciences Inc, Sygnature Discovery, Paraza Pharma, Inc, Dalriada, Inotiv, Eurofins Discovery, RTI International, Frontage Labs, Labcorp, Jubilant Biosys, Creative Biolabs, Evotec, Charles River, Anthem Bio Sciences, Molecular Diagnostic Services, Inc, Invitrocue, TCG Lifesciences Private Limited, Q 2 Solutions, WuXi AppTec, oncodesign service, Alliance Pharma, Inc, QPS Holdings, NUVISAN
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Drug Metabolism and Pharmacokinetics (DMPK) Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drug Metabolism and Pharmacokinetics (DMPK) Service Market report?

Ans: The main players in the Drug Metabolism and Pharmacokinetics (DMPK) Service Market are NuChem Sciences Inc, Sygnature Discovery, Paraza Pharma, Inc, Dalriada, Inotiv, Eurofins Discovery, RTI International, Frontage Labs, Labcorp, Jubilant Biosys, Creative Biolabs, Evotec, Charles River, Anthem Bio Sciences, Molecular Diagnostic Services, Inc, Invitrocue, TCG Lifesciences Private Limited, Q 2 Solutions, WuXi AppTec, oncodesign service, Alliance Pharma, Inc, QPS Holdings, NUVISAN

What are the Application segmentation covered in the Drug Metabolism and Pharmacokinetics (DMPK) Service Market report?

Ans: The Applications covered in the Drug Metabolism and Pharmacokinetics (DMPK) Service Market report are Pharmaceutical Research and Development, Biotechnology, Efficacy Testing, Others

What are the Type segmentation covered in the Drug Metabolism and Pharmacokinetics (DMPK) Service Market report?

Ans: The Types covered in the Drug Metabolism and Pharmacokinetics (DMPK) Service Market report are In Vivo Drug Metabolism and Pharmacokinetics Services, In Vitro Drug Metabolism and Pharmacokinetics Services

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 In Vivo Drug Metabolism and Pharmacokinetics Services
1.2.3 In Vitro Drug Metabolism and Pharmacokinetics Services
1.3 Market by Application
1.3.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Research and Development
1.3.3 Biotechnology
1.3.4 Efficacy Testing
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Perspective (2019-2030)
2.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Growth Trends by Region
2.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Metabolism and Pharmacokinetics (DMPK) Service Historic Market Size by Region (2019-2024)
2.2.3 Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Region (2025-2030)
2.3 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Dynamics
2.3.1 Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Trends
2.3.2 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Drivers
2.3.3 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Challenges
2.3.4 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Players by Revenue
3.1.1 Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Players by Revenue (2019-2024)
3.1.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Players (2019-2024)
3.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue
3.4 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Concentration Ratio
3.4.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue in 2023
3.5 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service Head office and Area Served
3.6 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service, Product and Application
3.7 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Metabolism and Pharmacokinetics (DMPK) Service Breakdown Data by Type
4.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Historic Market Size by Type (2019-2024)
4.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Type (2025-2030)
5 Drug Metabolism and Pharmacokinetics (DMPK) Service Breakdown Data by Application
5.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Historic Market Size by Application (2019-2024)
5.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2019-2030)
6.2 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2019-2024)
6.4 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2019-2030)
7.2 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2019-2024)
7.4 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2019-2030)
8.2 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2019-2030)
9.2 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2019-2024)
9.4 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2019-2030)
10.2 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NuChem Sciences Inc
11.1.1 NuChem Sciences Inc Company Details
11.1.2 NuChem Sciences Inc Business Overview
11.1.3 NuChem Sciences Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.1.4 NuChem Sciences Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.1.5 NuChem Sciences Inc Recent Development
11.2 Sygnature Discovery
11.2.1 Sygnature Discovery Company Details
11.2.2 Sygnature Discovery Business Overview
11.2.3 Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.2.4 Sygnature Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.2.5 Sygnature Discovery Recent Development
11.3 Paraza Pharma, Inc
11.3.1 Paraza Pharma, Inc Company Details
11.3.2 Paraza Pharma, Inc Business Overview
11.3.3 Paraza Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.3.4 Paraza Pharma, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.3.5 Paraza Pharma, Inc Recent Development
11.4 Dalriada
11.4.1 Dalriada Company Details
11.4.2 Dalriada Business Overview
11.4.3 Dalriada Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.4.4 Dalriada Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.4.5 Dalriada Recent Development
11.5 Inotiv
11.5.1 Inotiv Company Details
11.5.2 Inotiv Business Overview
11.5.3 Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.5.4 Inotiv Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.5.5 Inotiv Recent Development
11.6 Eurofins Discovery
11.6.1 Eurofins Discovery Company Details
11.6.2 Eurofins Discovery Business Overview
11.6.3 Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.6.4 Eurofins Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.6.5 Eurofins Discovery Recent Development
11.7 RTI International
11.7.1 RTI International Company Details
11.7.2 RTI International Business Overview
11.7.3 RTI International Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.7.4 RTI International Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.7.5 RTI International Recent Development
11.8 Frontage Labs
11.8.1 Frontage Labs Company Details
11.8.2 Frontage Labs Business Overview
11.8.3 Frontage Labs Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.8.4 Frontage Labs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.8.5 Frontage Labs Recent Development
11.9 Labcorp
11.9.1 Labcorp Company Details
11.9.2 Labcorp Business Overview
11.9.3 Labcorp Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.9.4 Labcorp Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.9.5 Labcorp Recent Development
11.10 Jubilant Biosys
11.10.1 Jubilant Biosys Company Details
11.10.2 Jubilant Biosys Business Overview
11.10.3 Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.10.4 Jubilant Biosys Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.10.5 Jubilant Biosys Recent Development
11.11 Creative Biolabs
11.11.1 Creative Biolabs Company Details
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.11.4 Creative Biolabs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.11.5 Creative Biolabs Recent Development
11.12 Evotec
11.12.1 Evotec Company Details
11.12.2 Evotec Business Overview
11.12.3 Evotec Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.12.4 Evotec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.12.5 Evotec Recent Development
11.13 Charles River
11.13.1 Charles River Company Details
11.13.2 Charles River Business Overview
11.13.3 Charles River Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.13.4 Charles River Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.13.5 Charles River Recent Development
11.14 Anthem Bio Sciences
11.14.1 Anthem Bio Sciences Company Details
11.14.2 Anthem Bio Sciences Business Overview
11.14.3 Anthem Bio Sciences Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.14.4 Anthem Bio Sciences Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.14.5 Anthem Bio Sciences Recent Development
11.15 Molecular Diagnostic Services, Inc
11.15.1 Molecular Diagnostic Services, Inc Company Details
11.15.2 Molecular Diagnostic Services, Inc Business Overview
11.15.3 Molecular Diagnostic Services, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.15.4 Molecular Diagnostic Services, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.15.5 Molecular Diagnostic Services, Inc Recent Development
11.16 Invitrocue
11.16.1 Invitrocue Company Details
11.16.2 Invitrocue Business Overview
11.16.3 Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.16.4 Invitrocue Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.16.5 Invitrocue Recent Development
11.17 TCG Lifesciences Private Limited
11.17.1 TCG Lifesciences Private Limited Company Details
11.17.2 TCG Lifesciences Private Limited Business Overview
11.17.3 TCG Lifesciences Private Limited Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.17.4 TCG Lifesciences Private Limited Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.17.5 TCG Lifesciences Private Limited Recent Development
11.18 Q 2 Solutions
11.18.1 Q 2 Solutions Company Details
11.18.2 Q 2 Solutions Business Overview
11.18.3 Q 2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.18.4 Q 2 Solutions Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.18.5 Q 2 Solutions Recent Development
11.19 WuXi AppTec
11.19.1 WuXi AppTec Company Details
11.19.2 WuXi AppTec Business Overview
11.19.3 WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.19.4 WuXi AppTec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.19.5 WuXi AppTec Recent Development
11.20 oncodesign service
11.20.1 oncodesign service Company Details
11.20.2 oncodesign service Business Overview
11.20.3 oncodesign service Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.20.4 oncodesign service Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.20.5 oncodesign service Recent Development
11.21 Alliance Pharma, Inc
11.21.1 Alliance Pharma, Inc Company Details
11.21.2 Alliance Pharma, Inc Business Overview
11.21.3 Alliance Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.21.4 Alliance Pharma, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.21.5 Alliance Pharma, Inc Recent Development
11.22 QPS Holdings
11.22.1 QPS Holdings Company Details
11.22.2 QPS Holdings Business Overview
11.22.3 QPS Holdings Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.22.4 QPS Holdings Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.22.5 QPS Holdings Recent Development
11.23 NUVISAN
11.23.1 NUVISAN Company Details
11.23.2 NUVISAN Business Overview
11.23.3 NUVISAN Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.23.4 NUVISAN Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
11.23.5 NUVISAN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
NuChem Sciences Inc
Sygnature Discovery
Paraza Pharma, Inc
Dalriada
Inotiv, Inc.
Eurofins Discovery
RTI International
Frontage Labs
LabCorp
Jubilant Biosys
Creative-Biolabs
Evotec AG
Charles River
Invitrocue
Q 2 Solutions
WuXi AppTec
Alliance Pharma Inc.
Nuvisan
Anthem Bio Sciences
Molecular Diagnostic Services, Inc
TCG Lifesciences Private Limited
oncodesign service
QPS Holdings
List of Tables
 Table 1. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of In Vivo Drug Metabolism and Pharmacokinetics Services
 Table 3. Key Players of In Vitro Drug Metabolism and Pharmacokinetics Services
 Table 4. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region (2019-2024)
 Table 8. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region (2025-2030)
 Table 10. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Trends
 Table 11. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Drivers
 Table 12. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Challenges
 Table 13. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Restraints
 Table 14. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Players (2019-2024)
 Table 16. Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service as of 2023)
 Table 17. Ranking of Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Companies by Revenue (US$ Million) in 2023
 Table 18. Global 5 Largest Players Market Share by Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service, Headquarters and Area Served
 Table 20. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service, Product and Application
 Table 21. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Type (2019-2024)
 Table 25. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Type (2025-2030)
 Table 27. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Application (2019-2024)
 Table 29. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Application (2025-2030)
 Table 31. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 32. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2019-2024) & (US$ Million)
 Table 33. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2025-2030) & (US$ Million)
 Table 34. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2019-2024) & (US$ Million)
 Table 36. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (2019-2024) & (US$ Million)
 Table 39. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2019-2024) & (US$ Million)
 Table 42. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2025-2030) & (US$ Million)
 Table 46. NuChem Sciences Inc Company Details
 Table 47. NuChem Sciences Inc Business Overview
 Table 48. NuChem Sciences Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 49. NuChem Sciences Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 50. NuChem Sciences Inc Recent Development
 Table 51. Sygnature Discovery Company Details
 Table 52. Sygnature Discovery Business Overview
 Table 53. Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 54. Sygnature Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 55. Sygnature Discovery Recent Development
 Table 56. Paraza Pharma, Inc Company Details
 Table 57. Paraza Pharma, Inc Business Overview
 Table 58. Paraza Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 59. Paraza Pharma, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 60. Paraza Pharma, Inc Recent Development
 Table 61. Dalriada Company Details
 Table 62. Dalriada Business Overview
 Table 63. Dalriada Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 64. Dalriada Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 65. Dalriada Recent Development
 Table 66. Inotiv Company Details
 Table 67. Inotiv Business Overview
 Table 68. Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 69. Inotiv Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 70. Inotiv Recent Development
 Table 71. Eurofins Discovery Company Details
 Table 72. Eurofins Discovery Business Overview
 Table 73. Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 74. Eurofins Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 75. Eurofins Discovery Recent Development
 Table 76. RTI International Company Details
 Table 77. RTI International Business Overview
 Table 78. RTI International Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 79. RTI International Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 80. RTI International Recent Development
 Table 81. Frontage Labs Company Details
 Table 82. Frontage Labs Business Overview
 Table 83. Frontage Labs Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 84. Frontage Labs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 85. Frontage Labs Recent Development
 Table 86. Labcorp Company Details
 Table 87. Labcorp Business Overview
 Table 88. Labcorp Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 89. Labcorp Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 90. Labcorp Recent Development
 Table 91. Jubilant Biosys Company Details
 Table 92. Jubilant Biosys Business Overview
 Table 93. Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 94. Jubilant Biosys Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 95. Jubilant Biosys Recent Development
 Table 96. Creative Biolabs Company Details
 Table 97. Creative Biolabs Business Overview
 Table 98. Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 99. Creative Biolabs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 100. Creative Biolabs Recent Development
 Table 101. Evotec Company Details
 Table 102. Evotec Business Overview
 Table 103. Evotec Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 104. Evotec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 105. Evotec Recent Development
 Table 106. Charles River Company Details
 Table 107. Charles River Business Overview
 Table 108. Charles River Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 109. Charles River Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 110. Charles River Recent Development
 Table 111. Anthem Bio Sciences Company Details
 Table 112. Anthem Bio Sciences Business Overview
 Table 113. Anthem Bio Sciences Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 114. Anthem Bio Sciences Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 115. Anthem Bio Sciences Recent Development
 Table 116. Molecular Diagnostic Services, Inc Company Details
 Table 117. Molecular Diagnostic Services, Inc Business Overview
 Table 118. Molecular Diagnostic Services, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 119. Molecular Diagnostic Services, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 120. Molecular Diagnostic Services, Inc Recent Development
 Table 121. Invitrocue Company Details
 Table 122. Invitrocue Business Overview
 Table 123. Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 124. Invitrocue Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 125. Invitrocue Recent Development
 Table 126. TCG Lifesciences Private Limited Company Details
 Table 127. TCG Lifesciences Private Limited Business Overview
 Table 128. TCG Lifesciences Private Limited Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 129. TCG Lifesciences Private Limited Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 130. TCG Lifesciences Private Limited Recent Development
 Table 131. Q 2 Solutions Company Details
 Table 132. Q 2 Solutions Business Overview
 Table 133. Q 2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 134. Q 2 Solutions Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 135. Q 2 Solutions Recent Development
 Table 136. WuXi AppTec Company Details
 Table 137. WuXi AppTec Business Overview
 Table 138. WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 139. WuXi AppTec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 140. WuXi AppTec Recent Development
 Table 141. oncodesign service Company Details
 Table 142. oncodesign service Business Overview
 Table 143. oncodesign service Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 144. oncodesign service Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 145. oncodesign service Recent Development
 Table 146. Alliance Pharma, Inc Company Details
 Table 147. Alliance Pharma, Inc Business Overview
 Table 148. Alliance Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 149. Alliance Pharma, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 150. Alliance Pharma, Inc Recent Development
 Table 151. QPS Holdings Company Details
 Table 152. QPS Holdings Business Overview
 Table 153. QPS Holdings Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 154. QPS Holdings Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 155. QPS Holdings Recent Development
 Table 156. NUVISAN Company Details
 Table 157. NUVISAN Business Overview
 Table 158. NUVISAN Drug Metabolism and Pharmacokinetics (DMPK) Service Product
 Table 159. NUVISAN Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024) & (US$ Million)
 Table 160. NUVISAN Recent Development
 Table 161. Research Programs/Design for This Report
 Table 162. Key Data Information from Secondary Sources
 Table 163. Key Data Information from Primary Sources
 Table 164. Authors List of This Report


List of Figures
 Figure 1. Drug Metabolism and Pharmacokinetics (DMPK) Service Picture
 Figure 2. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Type: 2023 VS 2030
 Figure 4. In Vivo Drug Metabolism and Pharmacokinetics Services Features
 Figure 5. In Vitro Drug Metabolism and Pharmacokinetics Services Features
 Figure 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Application (2024-2030) & (US$ Million)
 Figure 7. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Application: 2023 VS 2030
 Figure 8. Pharmaceutical Research and Development Case Studies
 Figure 9. Biotechnology Case Studies
 Figure 10. Efficacy Testing Case Studies
 Figure 11. Others Case Studies
 Figure 12. Drug Metabolism and Pharmacokinetics (DMPK) Service Report Years Considered
 Figure 13. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 14. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region: 2023 VS 2030
 Figure 16. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Players in 2023
 Figure 17. Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service as of 2023)
 Figure 18. The Top 10 and 5 Players Market Share by Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue in 2023
 Figure 19. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2019-2030)
 Figure 21. United States Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Canada Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2019-2030)
 Figure 25. Germany Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. France Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. U.K. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Italy Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Russia Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Nordic Countries Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region (2019-2030)
 Figure 33. China Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Japan Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. South Korea Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Southeast Asia Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. India Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Australia Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2019-2030)
 Figure 41. Mexico Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Brazil Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2019-2030)
 Figure 45. Turkey Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Saudi Arabia Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. UAE Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. NuChem Sciences Inc Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 49. Sygnature Discovery Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 50. Paraza Pharma, Inc Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 51. Dalriada Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 52. Inotiv Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 53. Eurofins Discovery Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 54. RTI International Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 55. Frontage Labs Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 56. Labcorp Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 57. Jubilant Biosys Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 58. Creative Biolabs Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 59. Evotec Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 60. Charles River Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 61. Anthem Bio Sciences Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 62. Molecular Diagnostic Services, Inc Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 63. Invitrocue Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 64. TCG Lifesciences Private Limited Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 65. Q 2 Solutions Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 66. WuXi AppTec Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 67. oncodesign service Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 68. Alliance Pharma, Inc Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 69. QPS Holdings Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 70. NUVISAN Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2019-2024)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global ADME DMPK Studies Market Research Report 2024
Global Preclinical DMPK Studies Market Research Report 2024
Global Drug Metabolism and Pharmacokinetics DMPK Market Research Report 2024
Global DMPK Service Market Research Report 2024
In Vivo and In Vitro DMPK and ADME Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vitro ADME Services Market
Global Pharmacokinetic Service Market Research Report 2025
Global Pharmacokinetics Testing Service Market Research Report 2024
Global PK PD Modeling Market Research Report 2024
Global In Vivo and In Vitro ADME Market Research Report 2024
In Vitro ADME Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vivo and In Vitro ADME and PK Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global In Vivo Pharmacology Service Market Research Report 2024
Global Pharmacology Discovery Service Market Research Report 2024
Global Radiolabelled ADME Studies Market Research Report 2024
Global Pharmacokinetic Research Service Market Research Report 2024
Global Pharmaceutical Characterization Service Market Research Report 2025
Global In Vitro ADME Testing Services Market Insights Forecast to 2030
Global Pharmacokinetic Research Market Research Report 2024
Global Drug Particle Engineering Service Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions